Analyst consensus rating
Ascentage Pharma Group International Analyst Rating: Strong Buy
Direct answer
Ascentage Pharma Group International's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $47.13.
Forecast evidence checked September 7, 2026.
Get free Ascentage Pharma Group International email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $17.62
- Average price target
- $47.13
- High price target
- $55.00
- Low price target
- $40.00
- Low target gap
- +127.1%
- Target upside
- +167.5%
- High target gap
- +212.2%
- Target range width
- 85.2%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- September 7, 2026
- Valid through
- September 14, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Ascentage Pharma Group International?
Ascentage Pharma Group International has a verified Strong Buy consensus. The same dataset has an average price target of $47.13.
How far are Ascentage Pharma Group International's low and high targets from the recorded price?
The low target implies +127.1%, while the high target implies +212.2%.
How many analysts are included in Ascentage Pharma Group International's consensus?
The verified consensus includes 8 analysts.
How is Ascentage Pharma Group International's target upside or downside calculated?
The average target of $47.13 is divided by the recorded price of $17.62, then one is subtracted to produce +167.5%. This does not guarantee a future return.
When was Ascentage Pharma Group International's analyst forecast verified?
The data was verified on 2026-09-07. The dataset is valid through 2026-09-14.